从China供应商批量进口2-Azabicyclo[2,2,1]Hept-5-En-3-One

Zhejiang Hongbo Chemical Co., Ltd. supplies 2-Azabicyclo[2,2,1]hept-5-en-3-one, a bicyclic lactam intermediate with a molecular formula of C6H7NO and a molecular weight of approximately 109.13 g/mol. The product is presented as a yellow to off-white solid, with a verified purity of 98.0% as determined by gas chromatography and a low water content of 0.5%, which is critical for stability in synthetic reactions. This specific lot data from the supplier provides a concrete quality baseline for procurement.

This compound is a key building block in pharmaceutical synthesis, most notably for producing the antiviral drug Abacavir. Its structure, featuring a strained bicyclic system with a lactam group, makes it valuable for constructing complex nitrogen-containing heterocycles. Typical industry specifications for such intermediates include melting point ranges (often 60-80°C for similar compounds), specific optical rotation data, and residual solvent limits, though these would need confirmation from the supplier for this particular batch.

Buyers for this material are primarily pharmaceutical manufacturers and contract research organizations (CROs) involved in antiviral or central nervous system drug development. The listing indicates bulk availability for both research and commercial-scale production. Sourcing terms should be confirmed directly with Zhejiang Hongbo, as the listing mentions flexible MOQ and references to ISO and FDA certifications, but the specific certificates, exact MOQ figures, and current pricing are not detailed in the provided data.

Zhejiang Hongbo Chemical Co., Ltd. is a chemical supplier based in Lianshi Town, Hangzhou, Zhejiang, China. The supplier's profile on the platform indicates a trust tier of 'harbor', which is a verification signal provided by the marketplace. However, the listing does not provide specific details about the company's founding year, production capacity, number of employees, or key clientele.

The product listing positions the company as a source of pharmaceutical intermediates. While the description mentions compliance with ISO and FDA standards, the specific certificates, registration numbers, or audit reports are not provided in the available data. For a prospective buyer, verifying the exact scope of these certifications and the supplier's export experience for regulated markets would be a necessary step.